Converge Bio (Series A)
Funding Details
Awarder
Inbox
Date Award
January 13, 2026
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount
$25,000,000
Company Info
Founding Year
2024
Founders
Dov Gertz, Iddo Weiner, Oded Kalev
Market
Pharmaceuticals
Location
Wilmington, DE, USA
Coinvestors
Bessemer Venture Partners, Saras Capital, TLV Partners, Vintage Investment Partners
Company Description

Converge Bio is an AI platform that enables biotech and pharmaceutical companies to accelerate drug discovery and development. Founded in 2024, Converge's 40-person team has deep expertise in machine learning, computational biology, and drug development; about half hold advanced degrees in related fields.

Links
Website
Back to HomeBack to Biotechnology DealsView Funding Announcement